GENELUX CORPORATION Operating Lease, Weighted Average Discount Rate, Percent
GENELUX CORPORATION (GNLX) had Operating Lease, Weighted Average Discount Rate, Percent of 9.70% as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-13
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 9.70%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.90%.
- 2025-06-30: Operating Lease, Weighted Average Discount Rate, Percent 6.50%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.50%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2026-06-30 | 9.70% 10-Q · filed 2026-08-13 |
| 2025-12-31 | 6.90% 10-K · filed 2026-03-19 |
| 2025-06-30 | 6.50% 10-Q · filed 2026-08-13 |
| 2024-12-31 | 6.50% 10-K · filed 2026-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |